Navigation Links
KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease
Date:1/9/2012

SOUTHAMPTON, ENGLAND and NEW YORK, Jan. 9, 2012 /PRNewswire-USNewswire/ -- KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million in milestone-based financial support and research expertise to KalVista. The goal of this partnership is to advance KalVista's lead pre-clinical candidate, a plasma kallikrein inhibitor, into human proof-of-concept clinical trials and to generate clinical data that would highlight its potential as an entirely new approach to treat diabetic macular edema (DME). DME is a leading cause of visual loss for people with T1D that involves swelling of the retina, which can lead to blurred vision and blindness.

Plasma kallikrein is an enzyme (a serine protease) that has been identified as a potential therapeutic target in people with diabetic retinopathy. Research has shown   that it contributes to increases in blood vessel leakage and thickening of the retina. Previous JDRF-funded studies led by one of KalVista's co-founders, Edward Feener, Ph.D., Associate Professor of Medicine at Harvard Medical School and Joslin Diabetes Center, demonstrated that plasma kallikrein is increased and activated in the vitreous fluid of people with DME . This data suggests that chronic activation of plasma kallikrein increases blood vessel inflammation and permeability by generating the production of a hormone called bradykinin, which causes blood vessels to dilate or enlarge. Plasma kallikrein inhibitors are believed to reduce retinal vessel leakage by suppressing the chronic and excessive production of bradykinin.

"Diabetic eye disease is a high priority research area for JDRF. Our support of Dr. Feener's academic research over the years
'/>"/>

SOURCE JDRF
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
2. Questcor Pharmaceuticals Reports Strong Finish to 2011
3. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
4. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
7. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
10. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
11. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Nektar Therapeutics (NASDAQ: ... announced positive results from its Phase 3 pivotal ... half-life recombinant factor VIII (rFVIII) treatment for hemophilia ... met its primary endpoint in reducing annualized bleed ... the on-demand arm. Top-line results from ...
(Date:8/21/2014)... TORONTO , Aug. 21, 2014 /CNW/ - The Canadian ... a new comic series designed to educate children about the ... epilepsy.  The Medikidz Explain Epilepsy comic series tells ... who is navigating middle school while living with epilepsy. ... 100 Canadians, there is still so much misinformation and lack ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans ... OxyContin is a serious public health and safety issue in ... from a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication ... progress with this very serious health situation facing our country," ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
(Date:8/23/2014)... 23, 2014 Professional kitchen employees, prospective ... aid in preparing for Food Safety Certification exams thanks ... by Dynamic Path. , Dynamic Path announced the release ... more than 200 review questions for culinary industry students ... to cover requirements of the ServSafe® Food Safety Certification, ...
(Date:8/23/2014)... Teen drug and alcohol abuse is ... in Wilmington, NC. Substance abuse can happen to people ... drug and alcohol dependency in higher numbers than ever ... substance abuse, but don’t know where to find professional ... be a challenge because most treatment options are designed ...
(Date:8/22/2014)... 2014 Deep Research Report on ... in-depth research report on the Glucose Meter market. ... Glucose Meter definition, classification, application, and industry chain ... covers the international market analysis, including domestic market ... environment & economic situation analysis. The report on ...
(Date:8/22/2014)... 23, 2014 Top 10 Best ... web hosting companies and highly recommended FatCow ( ... The manager of Top 10 Best SEO Hosting ... dedicated server hosting supplier. Actually, these companies have ... speed and customer support. People can get the ...
(Date:8/22/2014)... 2014 With the stage set for ... Store Expo - which will be held in Boston ... op-ed in its online opinion section, Podium. The ... is co-authored by Steven C. Anderson, IOM, CAE, president ... of the MCPHS University School of Pharmacy – Worcester/Manchester. ...
Breaking Medicine News(10 mins):Health News:Food Handler Safety Certification Made Easy with Dynamic Path 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3
... led by Dr. Bernhard Hering have reported the arrival of ... new $6.2 million, 21,000-square-foot Islet Resource Facility in Minneapolis, U.S. ... project- the Spring Point Project, a non- profit organization for ... ,This project will focus on the testing of ...
... 36-year-old professional body-builder who used growth hormone to boost his ... to a report. ,He was admitted with chest ... 12 months, during which he had also experienced excessive urination, ... for 15 years and artificial growth hormone for the past ...
... - The FDA has permitted the use of a ... drug known as Vyvanse//, is manufactured by Shire PLC. ... have a smooth transition from the older ADHD medications ... that the present drug is promising because it is ...
... doctors in Srinagar are quite frustrated by the large number ... bite cases// recorded by the main SMHS hospital here last ... in the last two months. 'The situation is alarming. We ... cases the victims are suspected to have been bitten by ...
... are under the impression that ovarian cancer can be detected ... that this wrong notion is more dangerous to the lives ... 610 women, out of which 305 thought that pap smear ... Breast Cancer Centre said that pap smear is not the ...
... education programme on cervical cancer prevention and the new vaccine ... organized by a team of doctors from Obstetrics and Gynecology ... ,Dr Rihab Awad of the hospital insisted on ... tests once a year. Any aberration detected in cervix can ...
Cached Medicine News:Health News:Pigs Arrive at Bio-secure Center 2
... a new generation Spectrophotometer for near ... nm to 1020 nm with built-in ... and printer. It features four digit ... transmittance, absorption and concentration with excellent ...
... 400 Series Spectrophotometer is ... to UV-VIS instrumentation. The ... incorporated into a radically ... features and performance unprecedented ...
... 520 General Purpose UV/Vis Spectrophotometer. Beckman ... proven technology for a wide range ... 500 Scanning Spectrophotometers, with easily interchangeable ... use. A totally affordable, completely modular ...
... user to quickly and accurately count bacteria colonies. ... or manual counting. An optional 1.5X auxiliary lens ... 3.0X. The adjustable focusing rod allows the 1.5X ... lens also rotates a full 360 for ready ...
Medicine Products: